Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient
Background: Anti-programmed cell death protein 1 (PD-1) has been successfully used in carcinomas treatment. However, it causes significant adverse effects (AEs), including cutaneous reactions, particularly the life-threatening severe bullous skin reactions (SBSR) and toxic epidermal necrolysis (TEN)...
Main Authors: | Xiang Li, Li-Xin Qu, Yu-Mei Ren, Chang Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.707967/full |
Similar Items
-
Bullous pemphigoid secondary to pembrolizumab mimicking toxic epidermal necrolysis
by: Connie Qiu, BS, et al.
Published: (2020-05-01) -
Bullous Drug Reactions
by: Maja Mockenhaupt
Published: (2020-02-01) -
Bullous fixed drug eruption following ibuprofen ingestion
by: Seyed Amirhossein Fazeli, et al.
Published: (2018-01-01) -
Toxic epidermal necrolysis secondary to ceftriaxone use: A case report
by: Mustafa İçer, et al.
Published: (2015-12-01) -
Allopurinol Induced Stevens – Johnson Syndrome - A Case Report
by: Sabyasachi Paik, et al.
Published: (2015-02-01)